Mucormycosis in Hematopoietic Cell Transplant Recipients and in Patients With Hematological Malignancies in the Era of New Antifungal Agents.

Matthew A MillerKyle C MolinaJonathan A GutmanSias SchergerJessica M LumSherif B MossadMary BurgessMatthew P ChengSally T ChuangSamantha E JacobsDante P MelendezDimpy P ShahAndrea ZimmerM Rizwan SohailSadia SyedRandall C WalkerEric M PoeschlaMaheen Z Abidi

Published in: Open forum infectious diseases (2020)

Long-term survival with IM among HM and HCT populations remains poor. However, initial use of AmB + azole in conjunction with surgery may result in less treatment failure. More evidence from prospective controlled studies is needed to confirm this observation.

Keyphrases

candida albicans
minimally invasive
single cell
bone marrow
coronary artery bypass
cell therapy
surgical site infection
replacement therapy
coronary artery disease
signaling pathway
acute coronary syndrome
cell death
genetic diversity
smoking cessation